Literature DB >> 31084520

Islet amyloidosis in a child with type 1 diabetes.

Maria L Beery1, Laura M Jacobsen2, Mark A Atkinson1,2, Alexandra E Butler3, Martha Campbell-Thompson1.   

Abstract

Histopathology based studies of the pancreas obtained from organ donors are increasing our awareness of islet phenotypic heterogeneity during development and aging, as well as in settings of type 1 diabetes, type 2 diabetes, monogenic diabetes or other forms of this metabolic disease. Islet amyloidosis represents a histopathological feature classically ascribed to patients with type 2 diabetes. Herein, the occurrence of islet amyloidosis and its severity are reported in a child with type 1 diabetes along with histological comparisons of islet amyloidosis in two young adults with recent-onset type 1 diabetes. Islet amyloidosis was infrequent yet widely distributed throughout the pancreas in the child with type 1 diabetes and both adults with type 1 diabetes, with no such pathology seen in matched control donors. Analysis of these cases add to the increasing appreciation of islet heterogeneity in children and young adults with type 1 diabetes. Such knowledge also supports a notion that multiple pathophysiological mechanisms underlie the loss of functional β-cell mass in the spectrum of clinical phenotypes in patients with type 1 diabetes.

Entities:  

Keywords:  Histopathology; amylin; heterogeneity; insulitis; islet amyloid polypeptide; pancreas

Mesh:

Year:  2019        PMID: 31084520      PMCID: PMC6548483          DOI: 10.1080/19382014.2019.1599707

Source DB:  PubMed          Journal:  Islets        ISSN: 1938-2014            Impact factor:   2.694


  17 in total

1.  Human type 2 diabetes: morphological evidence for abnormal beta-cell function.

Authors:  C Sempoux; Y Guiot; D Dubois; P Moulin; J Rahier
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  Widespread amyloid deposition in transplanted human pancreatic islets.

Authors:  Gunilla T Westermark; Per Westermark; Christian Berne; Olle Korsgren
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

3.  Insulin Expressing Pancreatic Neuroendocrine Tumor Associated With Intratumor Amyloidosis.

Authors:  Rohini R Vanga; Sadhna Dhingra; Kalpesh Patel
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-22       Impact factor: 11.382

4.  Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.

Authors:  Rebecca L Hull; Ronald L Gibson; Sharon McNamara; Gail H Deutsch; Corinne L Fligner; Charles W Frevert; Bonnie W Ramsey; Srinath Sanda
Journal:  Diabetes Care       Date:  2018-02-01       Impact factor: 19.112

5.  Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA.

Authors:  May Sanyoura; Laura Jacobsen; David Carmody; Daniela Del Gaudio; Gorka Alkorta-Aranburu; Kelly Arndt; Ying Hu; Frances Kobiernicki; Irina Kusmartseva; Mark A Atkinson; Louis H Philipson; Desmond Schatz; Martha Campbell-Thompson; Siri Atma W Greeley
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

Review 6.  Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

Authors:  A Clark; M R Nilsson
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

7.  Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis.

Authors:  T D O'Brien; A E Butler; P C Roche; K H Johnson; P C Butler
Journal:  Diabetes       Date:  1994-02       Impact factor: 9.461

8.  Islet amyloid in recent-onset type 1 diabetes-the DiViD study.

Authors:  Gunilla T Westermark; Lars Krogvold; Knut Dahl-Jørgensen; Johnny Ludvigsson
Journal:  Ups J Med Sci       Date:  2017-08-17       Impact factor: 2.384

9.  β-Cell failure in type 2 diabetes: a case of asking too much of too few?

Authors:  Safia Costes; Ralf Langen; Tatyana Gurlo; Aleksey V Matveyenko; Peter C Butler
Journal:  Diabetes       Date:  2013-02       Impact factor: 9.461

10.  Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.

Authors:  Martha Campbell-Thompson; Ann Fu; John S Kaddis; Clive Wasserfall; Desmond A Schatz; Alberto Pugliese; Mark A Atkinson
Journal:  Diabetes       Date:  2015-11-18       Impact factor: 9.461

View more
  7 in total

Review 1.  Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure.

Authors:  Décio L Eizirik; Lorenzo Pasquali; Miriam Cnop
Journal:  Nat Rev Endocrinol       Date:  2020-05-12       Impact factor: 43.330

Review 2.  Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes.

Authors:  Abu Saleh Md Moin; Alexandra E Butler
Journal:  Curr Diab Rep       Date:  2019-08-10       Impact factor: 4.810

Review 3.  Amyloid Proteins and Peripheral Neuropathy.

Authors:  Mohammed M H Asiri; Sjoukje Engelsman; Niels Eijkelkamp; Jo W M Höppener
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

4.  Pancreatlas: Applying an Adaptable Framework to Map the Human Pancreas in Health and Disease.

Authors:  Diane C Saunders; James Messmer; Irina Kusmartseva; Maria L Beery; Mingder Yang; Mark A Atkinson; Alvin C Powers; Jean-Philippe Cartailler; Marcela Brissova
Journal:  Patterns (N Y)       Date:  2020-10-05

Review 5.  Endoplasmic Reticulum-Mitochondria Crosstalk and Beta-Cell Destruction in Type 1 Diabetes.

Authors:  Saurabh Vig; Joost M Lambooij; Arnaud Zaldumbide; Bruno Guigas
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

Review 6.  Organisation of the human pancreas in health and in diabetes.

Authors:  Mark A Atkinson; Martha Campbell-Thompson; Irina Kusmartseva; Klaus H Kaestner
Journal:  Diabetologia       Date:  2020-09-07       Impact factor: 10.460

7.  Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrPC, in type 1 diabetes.

Authors:  Helmut Hiller; Changjun Yang; Dawn E Beachy; Irina Kusmartseva; Eduardo Candelario-Jalil; Amanda L Posgai; Harry S Nick; Desmond Schatz; Mark A Atkinson; Clive H Wasserfall
Journal:  Diabetologia       Date:  2021-07-17       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.